logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Cytomegalovirus Retinitis

    Medications for Cytomegalovirus Retinitis

    FiltersReset Filters
    9 results

    • foscavir

      (foscarnet sodium)
      Clinigen Limited
      Usage: FOSCAVIR is indicated for treating CMV retinitis in AIDS patients and for acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. Its safety and efficacy have not been established for other CMV or HSV infections, in congenital or neonatal cases, or in non-immunocompromised individuals.

    • foscavir

      (foscarnet sodium)
      Clinigen Limited
      Usage: FOSCAVIR is indicated for treating CMV retinitis in AIDS patients and for acyclovir-resistant mucocutaneous HSV infections in immunocompromised individuals. Its safety and efficacy are not established for other CMV or HSV infections, including those in non-immunocompromised patients.

    • ganciclovir sodium

      (ganciclovir sodium)
      Slate Run Pharmaceuticals, LLC
      Usage: Ganciclovir for Injection is indicated for treating cytomegalovirus (CMV) retinitis in immunocompromised adults, including those with AIDS, and for preventing CMV disease in at-risk adult transplant recipients.

    • valcyte

      (valganciclovir)
      H2-Pharma, LLC
      Usage: VALCYTE is indicated for the treatment of cytomegalovirus (CMV) retinitis in adults with AIDS and for the prevention of CMV disease in high-risk kidney and heart transplant patients. It is also used in pediatric patients (4 months to 16 years) for preventing CMV disease post-kidney or heart transplant.

    • valganciclovir

      (Valganciclovir hydrochloride powder,)
      Aurobindo Pharma Limited
      Usage: Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients. The oral solution is also indicated for preventing CMV disease in pediatric patients (1 month to 16 years) undergoing kidney and heart transplants.

    • valganciclovir

      (Valganciclovir)
      Ajanta Pharma USA Inc.
      Usage: Valganciclovir tablets are indicated for treating Cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients. It is also used in pediatric patients aged 1 month to 16 years for preventing CMV disease post-transplant.

    • valganciclovir hydrochloride

      (VALGANCICLOVIR)
      Somerset Therapeutics, LLC
      Usage: Valganciclovir hydrochloride is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients. It is also used in pediatric patients aged 1 month to 16 years for CMV disease prevention in transplant scenarios.

    • valganciclovir hydrochloride

      (VALGANCICLOVIR HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Valganciclovir tablets are indicated for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients and for the prevention of CMV disease in high-risk kidney, heart, and kidney-pancreas transplant patients, as well as in pediatric kidney and heart transplant patients aged 1 month to 16 years.

    • valganciclovir hydrochloride

      (Valganciclovir hydrochloride)
      Ajanta Pharma USA Inc.
      Usage: Valganciclovir is indicated for treating cytomegalovirus (CMV) retinitis in AIDS patients and for preventing CMV disease in high-risk transplant recipients (adults and pediatric patients) including kidney and heart transplants.